Edward Tenthoff
#117 out of 1697 analysts
Piper Sandler
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
84.83%
Gain -3.96%
Monthly
-0.61%
Yearly
-7.07%
Drawdown
72.29%
$60,870.33
Equity
Holdings
$52,686.37
Cash
$8,183.96
Investment
$65,821.36
-$39,129.67
Profit -$2,508.65
Realized
-$25,994.68
Unrealized
-$13,134.98
Dividends
$0
$8,183.96
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-3.96%
Profit
-$2,508.65
Win %
0%
This Week
Compared To Last Week
Gain
-13.36%
Profit
-$9,387.06
Win %
0%
This Month
Compared to last month
Gain
-19.53%
Profit
-$14,773.7
Win %
15%
This Year
Compared to last year
Gain
-53.18%
Profit
-$69,145.19
Win %
45%
No Data
CAPR Capricor Therapeutics Inc.
-7.15%
-$475.49 
DYN Dyne Therapeutics Inc.
-5.75%
-$473.81 
MESO Mesoblast Limited Sponsored ADR
-4.8%
-$389.44 
FATE Fate Therapeutics Inc.
-4.67%
-$316.12 
KPTI Karyopharm Therapeutics Inc.
-3.79%
-$135.72 
CAMP Camp4 Therapeutics Corp.
-3.48%
-$245.21 
ARWR Arrowhead Pharmaceuticals Inc.
-3.24%
-$241.6 
INO Inovio Pharmaceuticals, Inc.
-2.88%
-$211.65 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 1654 | Longs Won 636/1642 38% | Profit Factor 0.91 |
| Profitability | Shorts Won 0/12 0% | Standard Deviation $1,623.1 |
| Average Win $596.8 | Best Trade (Jul 24) $31,963.2 | Sharpe Ratio -236.6 |
| Average Loss -$411.29 | Worst Trade (Nov 29) -$17,890.77 | Z-Score -13.38 (100%) |
| Commissions $0 | Avg. Trade Length 1m 2w 1d | Expectancy -$23.66 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 148 | 133 | 118 | 104 | 89 | 74 | 59 | 44 | 30 | 15 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals Inc. | 127.5 | $8,183.96 | $7,216.9 | - | -$967.06 | -11.82% | -3.239% |
| CAMP Camp4 Therapeutics Corp. | 2,043.44 | $7,989.83 | $6,804.64 | - | -$1,185.19 | -14.83% | -3.478% |
| CAPR Capricor Therapeutics Inc. | 914.41 | $8,183.96 | $6,172.26 | - | -$2,011.7 | -24.58% | -7.153% |
| DYN Dyne Therapeutics Inc. | 538.42 | $8,727.76 | $7,758.61 | - | -$969.15 | -11.1% | -5.755% |
| FATE Fate Therapeutics Inc. | 3,512.43 | $8,183.96 | $6,445.31 | - | -$1,738.65 | -21.24% | -4.675% |
| INO Inovio Pharmaceuticals, Inc. | 7,055.14 | $8,183.96 | $7,125.69 | - | -$1,058.27 | -12.93% | -2.885% |
| KPTI Karyopharm Therapeutics Inc. | 10,204.44 | $8,183.96 | $3,444 | - | -$4,739.96 | -57.92% | -3.791% |
| MESO Mesoblast Limited Sponsored ADR | 581.25 | $8,183.96 | $7,718.96 | - | -$465 | -5.68% | -4.803% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
2026 © Marketlog. All Rights Reserved.
